Brief: Patients With Uveal Melanoma Tested With Decisiondx-Um Report Gaining Value From Test Results In Study Conducted In Collaboration With The Melanoma Research Foundation’S Cure Om Initiative

Castle Biosciences

23/06/2022 22:00

June 23 (Reuters) - Castle Biosciences Inc  CSTL.O :
    * PATIENTS WITH UVEAL MELANOMA TESTED WITH DECISIONDX®-UM
REPORT
GAINING VALUE FROM TEST RESULTS IN STUDY CONDUCTED IN
COLLABORATION WITH THE MELANOMA RESEARCH FOUNDATION’S CURE OM
INITIATIVE

Source text for Eikon:  ID:nBw7HWqqwa 
Further company coverage:  CSTL.O 

 ((Reuters.Briefs@thomsonreuters.com;))